Dashboard
Manage Tickers

PENPenumbra Inc

NYSE penumbrainc.com


$ 207.93 $ -1.31 (-0.63 %)    

Friday, 10-May-2024 11:23:40 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.47 $ -1.41 (-0.32 %)
DIA $ 394.56 $ -0.70 (-0.18 %)
SPY $ 520.27 $ -1.25 (-0.24 %)
TLT $ 90.08 $ -0.23 (-0.25 %)
GLD $ 218.78 $ -1.00 (-0.46 %)
$ 209.4
$ 209.24
$ 0.00 x 0
$ 210.51 x 100
$ 206.88 - $ 209.36
$ 180.93 - $ 348.67
380,712
na
8.25B
$ 1.10
$ 88.31
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-01-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-23-2021 12-31-2020 10-K
15 11-02-2020 09-30-2020 10-Q
16 08-03-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-05-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-08-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

canaccord-genuity-maintains-buy-on-penumbra-lowers-price-target-to-272
Canaccord Genuity Maintains Buy on Penumbr...
05/08/2024 16:52:18

Canaccord Genuity analyst Jason Mills maintains Penumbra (NYSE:PEN) with a Buy and lowers the price target from $284 to $272.

piper-sandler-maintains-overweight-on-penumbra-lowers-price-target-to-260
Piper Sandler Maintains Overweight on Penu...
05/08/2024 16:06:05

Piper Sandler analyst Matt O'Brien maintains Penumbra (NYSE:PEN) with a Overweight and lowers the price target from $290...

the-latest-analyst-ratings-for-penumbra
The Latest Analyst Ratings For Penumbra
05/08/2024 14:00:29

needham-reiterates-hold-on-penumbra
Needham Reiterates Hold on Penumbra
05/08/2024 12:20:19

Needham analyst Mike Matson reiterates Penumbra (NYSE:PEN) with a Hold.

penumbra-reiterates-fy24-revenue-1230b-1270b-vs-1246b-est
Penumbra Reiterates FY24 Revenue $1.230B-$...
05/07/2024 21:20:52

penumbra-q1-adj-041-beats-038-estimate-sales-27865m-beat-27489m-estimate
Penumbra Q1 Adj $0.41 Beats $0.38 Estimate...
05/07/2024 20:18:02

Penumbra (NYSE:PEN) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.38 by 7.89 p...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/07/2024 17:35:23

penumbra-announced-the-us-food-and-drug-administration-clearance-and-launch-of-lightning-flash-20-designed-to-rapidly-remove-blood-clots
Penumbra Announced The US Food And Drug Ad...
04/23/2024 13:04:52

jim-cramer-was-upset-at-this-hostile-takeover-but-they-fixed-the-situation-stocks-been-a-horse
Jim Cramer Was Upset At This Hostile Takeo...
04/09/2024 13:10:29

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over

piper-sandler-reiterates-overweight-on-penumbra-maintains-290-price-target
Piper Sandler Reiterates Overweight on Pen...
04/03/2024 15:38:59

Piper Sandler analyst Matt O'Brien reiterates Penumbra (NYSE:PEN) with a Overweight and maintains $290 price target.

penumbra-stock-a-deep-dive-into-analyst-perspectives-8-ratings
Penumbra Stock: A Deep Dive Into Analyst P...
03/22/2024 14:00:52

truist-securities-maintains-buy-on-penumbra-lowers-price-target-to-280
Truist Securities Maintains Buy on Penumbr...
03/22/2024 13:22:53

Truist Securities analyst Richard Newitter maintains Penumbra (NYSE:PEN) with a Buy and lowers the price target from $290 to...

why-mercadolibre-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why MercadoLibre Shares Are Trading Lower ...
02/23/2024 19:07:11

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter fin...

rbc-capital-reiterates-outperform-on-penumbra-maintains-289-price-target
RBC Capital Reiterates Outperform on Penum...
02/23/2024 16:30:38

RBC Capital analyst Shagun Singh reiterates Penumbra (NYSE:PEN) with a Outperform and maintains $289 price target.

canaccord-genuity-reiterates-buy-on-penumbra-maintains-284-price-target
Canaccord Genuity Reiterates Buy on Penumb...
02/23/2024 15:05:59

Canaccord Genuity analyst William Plovanic reiterates Penumbra (NYSE:PEN) with a Buy and maintains $284 price target.

intuit-to-rally-around-14-here-are-10-top-analyst-forecasts-for-friday
Intuit To Rally Around 14%? Here Are 10 To...
02/23/2024 13:22:20

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

where-penumbra-stands-with-analysts
Where Penumbra Stands With Analysts
02/23/2024 12:00:44

jp-morgan-downgrades-penumbra-to-neutral-lowers-price-target-to-250
JP Morgan Downgrades Penumbra to Neutral, ...
02/23/2024 11:17:27

JP Morgan analyst Robbie Marcus downgrades Penumbra (NYSE:PEN) from Overweight to Neutral and lowers the price target from $...

penumbra-sees-fy24-revenue-123b-127b-vs-1267b-est
Penumbra Sees FY24 Revenue $1.23B-$1.27B V...
02/22/2024 21:52:35

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
02/22/2024 21:31:07

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION